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Running Title: Caspase-8 and the inflammasome 
Summary: Caspase-8 is an apical component of cell death pathways. Activated caspase-8 can 
drive classical caspase-dependent apoptosis and actively inhibits cell death mediated by RIPK3-
driven necroptosis. Genetic deletion of Casp8 results in embryonic lethality as a result of 
uncontrolled necroptosis. This lethality can be rescued by simultaneous deletion of Ripk3. 
Recently, caspase-8 has been additionally connected to inflammatory pathways within the cell. 
In particular caspase-8 has been shown to be crucially involved in the induction of pro-IL-1β 
synthesis and processing via both non-canonical and canonical pathways. In this review, we 
bring together current knowledge regarding the role of caspase-8 in cellular inflammation with a 
particular emphasis on the interplay between caspase-8 and the classical and non-canonical 
inflammasomes.   
 
Keywords: interleukin-1β, caspase, inflammasome, apoptosis, death receptor, signal 
transduction 
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Introduction 
Caspases have been historically broadly classified into two types based upon their impact on cell 
fate: the inflammatory caspases ([caspases 1, 11 (4 and 5 in humans) and 12], and the apoptotic, 
or executioner, caspases (caspases 2, 3, 6, 7, 8, 9 and 10) (1). Over the last few years, our 
understanding of the different roles and functionality of some of these caspases has developed. 
As such, it has become apparent that this initial delineation is an oversimplification of caspase 
activity. In this review, we address the recent advances in our knowledge regarding the role of 
caspase-8 in the inflammatory response, particularly in relation to its function in inflammasome-
mediated signalling, and in the synthesis and processing of pro-interleukin-1β (IL-1β).  
 
Caspase-8 
Caspase-8 is located on chromosome 1 in mice and chromosome 2 in humans. Genetic ablation 
of Casp8 in mice results in embryonic lethality at the e10.5 stage (2). This phenotype can be 
rescued by the simultaneous removal of Ripk3(receptor-interacting serine/threonine-protein 
kinase 3), consistent with a role for caspase-8 in controlling RIPK3-dependent cell death 
processes (3, 4). Although these double knockout mice are viable, they ultimately develop 
lymphoproliferative disease.  Like other caspases, caspase-8 is translated as a monomeric 
zymogen consisting of a prodomain followed by both a large and small catalytic subunit (Fig. 1). 
In caspase-8, the prodomain consists of two death effector domains (DEDs) that facilitate 
interaction with other cellular proteins and mediate homotypic interactions to induce caspase-8 
dimerization and autoactivation by an induced proximity mechanism (Fig. 1). Activation of 
caspase-8 requires cleavage between the large and small catalytic subunits, specifically at the 
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aspartic acid residues D374 and D384. These cleavage events serve to stabilize the caspase-8 
protein and can then be followed by further cleavage at D216 between the prodomain and large 
catalytic subunit (5). Interestingly, there is increasing evidence that the functionality of caspase-8 
is related to the extent of molecular cleavage, with pro-apoptotic functions requiring a higher 
degree of processing. This may of course represent a cellular self-preservation strategy and 
ensure that apoptosis mediated by activation of death receptors is so finely tuned that cell death 
can only occur following a sufficiently robust level of receptor activation. 
 
The traditional role of caspase-8 in apoptotic and necroptotic cell death 
Classically caspase-8 has been associated with both apoptotic and necroptotic forms of cell 
death. Indeed when activated, caspase-8 serves both a pro-apopototic role and in addition 
functions as an inhibitor of necroptosis. Full consideration of these functions of caspase-8 is 
beyond the scope of this article. However, we refer the reader to a number of recent reviews that 
provide a detailed overview of the role of caspase-8 in cell death processing (1, 6–10). Briefly, 
activation of pattern recognition receptors such as TLR3 (Toll-like receptor 3), TLR4, DAI 
(DNA-dependent activator of interferons), and potentially RIG-I (retinoic acid inducible gene I) 
and MDA5 (melanoma differentiation-associated antigen 5) can stimulate necroptosis; however, 
it is ligation of death receptors in the plasma membrane that has been most extensively studied in 
relation to caspase-8 and cell death. Activation of CD95, TRAIL-R1/2 [tumor necrosis factor 
(TNF) apoptosis-inducing ligand receptor ½] or TNFR1 (TNF receptor 1) all result in the 
formation of multiprotein complexes involving caspase-8 (Fig. 2). The recruitment of FADD 
(Fas cell surface death receptor-associated death domain protein) to either CD95 or TRAIL-R1/2 
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induces formation of the membrane associated death-inducing signalling complex (DISC), which 
recruits and then activates caspase-8.  
Caspase-8 activation occurs via a two-step mechanism which begins with dimerization 
(11, 12). Dimerization of caspase-8 leads to a proximity-induced mechanism of autoproteolytic 
activation. Dimeric caspase-8, however, shows only low levels of proteolytic activity. This 
results in cleavage being limited to other proximal caspase-8 molecules and a restricted set of 
substrates within the DISC. Subsequent processing of the linker peptide between the catalytic 
subunits leads to an enhancement in the proteolytic activity of caspase-8 and a related increase in 
the range of available substrates. Caspase-8 now becomes able to process classical apoptotic 
caspases, such as caspase-3 and caspase-9, and as a result leads to the initiation of apoptotic cell 
death (Fig. 2). The activation of caspase-8 can be regulated and controlled by two isoforms of a 
non-catalytic caspase-8 paralogue cFLIPL (cellular FADD-like IL-1β-converting enzyme-like 
inhibitory protein long form) and cFLIPs (short form), which heterodimerize with caspase-8 and 
inhibit its activity (13). Additional caspase-8 containing complexes are released into the 
cytoplasm from where they are believed to augment caspase processing and phagocytosis of 
apoptotic cells by macrophages (14, 15). Interestingly, application of mathematical modeling 
coupled to experimental observations has recently been employed to investigate the mechanism 
of caspase-8 activation at both the level of the single cell and also cell populations (16). The 
authors of this study have put forward a model of DISC-mediated caspase-8 activation in which 
cleavage between the prodomain and catalytic domains is mediated in cis within the individual 
DISC. However, cleavage between the catalytic domains is proposed to occur in a trans-based 
manner and therefore requires the association of multiple and distinct DISCs. It is suggested that 
this method of activation allows the cell to balance the degree of caspase-8 activation to reflect 
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either low-level or high-level stimulation. This would in turn provide a molecular timing switch 
for caspase-8-mediated cell death (16). 
Activation of another death receptor, TNFR1, leads to the formation of an alternative pro-
survival multi-protein complex known as Complex I at the plasma membrane. Complex I 
consists of, amongst other proteins, TNFR-associated factors 2 and 5, TRADD (TNFR1-
associated death domain), cellular inhibitor of apoptosis (cIAP) 1 and 2 and RIPK1, and is 
tightly regulated by ubiquitylation. Ultimately recruitment of the IKK [inhibitor of nuclear factor 
κB (NFκB) kinase] complex results in activation of NFκB signaling pathways. Internalization of 
ligand-bound TNFR1 leads to a compositional shift in the complex and the formation of a 
cytoplasmic Complex II. Complex II, also known as the ‘TRADDosome’ (17) normally contains 
TRADD, FADD, RIPK1, RIPK3, and caspase-8 and forms following the deubiquitylation of 
RIPK1 by either of the proteins A20 or cylindromatosis. This complex activates caspase-8 and 
promotes the apoptotic pathway of cell death and serves to actively inhibit necroptosis by direct 
cleavage of RIPK1 and RIPK3. If cFLIPL is incorporated into Complex II this inhibits the 
apoptotic pathway and helps maintain the induction of NFκB signaling pathways.  
In the absence of caspase-8 following genetic ablation, pharmacological inhibition, or as 
a result of certain viral infections, RIPK1 and RIPK3 are not cleaved, and instead RIPK3 
becomes phosphorylated by RIPK1 leading to the initiation of necroptotic cell death through 
formation of the necrosome (Fig. 2). Assembly of the necrosome can also occur as a result of 
either the loss or the inhibition of IAPs (inhibitor of apoptosis proteins), which are primarily 
known for inhibiting apoptotic caspase activity by binding via evolutionary conserved 
baculoviral IAP repeat motifs and acting as ubiquitin ligases through their  RING (really 
interesting new gene) finger E3 ligase domain.  IAPs also have a role in the negative regulation 
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of the inflammatory response by limiting RIPK3-dependent activation of the inflammasome 
receptor NLRP3 (NLR family, pyrin domain containing 3)(18). Following formation of the 
necrosome, a series of downstream effector molecules are activated. These include the 
serine/threonine protein phosphatase PGAM5, mitochondrial and the mixed lineage kinase 
domain-like protein (19, 20). It has been proposed that these proteins mediate the propagation of 
necroptosis through facilitation of pore formation in the cellular membrane (21). Necroptosis is 
an inherently inflammatory process in nature due to the release of cellular contents that act as 
either pro-inflammatory stimuli, such as ATP and high mobility group proteins, or are 
themselves pro-inflammatory cytokines, for example IL-33 and IL-1α (22). 
 
Caspase-8 and the inflammasome 
The cellular responses to infection, damage, and threat are wide and varied. Over the last decade 
or so, the importance of a cytoplasmic multi-protein complex known as the inflammasome has 
become apparent, not just in terms of its role combating infection but also more generically in 
relation to activation of a pro-inflammatory immune response (23, 24). Inflammasome activation 
requires two signals. ‘Signal 1’ to upregulate the cellular levels of pro-IL-1β as well as 
inflammasome components such as the NLR (nucleotide binding, leucine-rich repeat containing 
receptor) family member NLRP3 and ‘Signal 2’ to initiate inflammasome activation and 
cytokine processing and secretion (23, 25, 26). Signal 1 is often provided as a result of 
upregulated NFκB signaling following the activation of TLR or NOD1/2 (nucleotide 
oligomerization domain 1/2) pathways. Signal 2, on the other hand, takes the form of a particular 
activatory ligand specific for certain inflammasome receptors (27). Examples of activatory 
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ligands include ATP, uric acid crystals, nigericin, dsDNA, the bacterial protein flagellin, and the 
anthrax lethal toxin. The classical canonical inflammasome is a complex of an activated receptor, 
the adapter protein ASC (apoptosis-associated speck-like protein containing a CARD), and an 
effector caspase that triggers cell death and processes pro-IL-1β and pro-IL-18 into their active 
forms ready for release from the cell (23, 28). To date, there are four canonical inflammasomes, 
formation of which is mediated by activation of one or more of the NLR family members 
NLRP1, NLRP3, and NLRC4 (NLR family, CARD domain containing 4)/NAIP (neuronal 
apoptosis inhibitory protein) or the interferon-inducible protein AIM2 (absent in melanoma 2). 
Receptor activation serves to act as a nucleation signal for the self-association of ASC leading to 
the formation of a very large cellular complex, which has a rough diameter of around one micron 
(24). This multiprotein complex is often referred to as a ‘speck’. The speck then serves as a focus 
for the recruitment of effector caspases, which under classical canonical conditions is caspase-1 
(23, 28, 29). Caspase-1 is subsequently activated, also as with caspase-8 via a proximity-induced 
mechanism, and then processes pro-IL-1β and pro-IL-18 into their active forms prior to their 
release from the cell. Caspase-1 can also mediated pyroptosis, a caspase-1 dependent mechanism 
of cell death (30, 31). Non-canonical inflammasomes trigger similar cellular processes but the 
mechanisms by which this is achieved are different (24).   
Caspase-8 was not originally thought to be involved in inflammasome activity. However, 
recent work suggests in fact that caspase-8 does play an unexpected and important effector role 
in both canonical and non-canonical inflammasomes, roles which we expand on below. As a 
point of clarification, much of the experimental data obtained in studying the role of caspase-8 in 
the inflammasome has been generated either using caspase-8 inhibitors, through the use of mice 
with lineage or cell-specific Casp8 deletions (sometimes genetic, sometimes inducible), or in a 
Page 8 of 44Immunological Reviews: Submitted manuscript
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
9 
 
Casp8-/-RIPK3-/- double knockout background. This approach is due to the embryonic lethality of 
caspase-8 ablation, which results in uncontrolled necroptotic death (2–4).  
 
Integrating caspase-8 and ASC in cell death 
ASC activation and speck formation has been associated with multiple types of cell death. These 
include apoptosis, necrosis, caspase-1 dependent pyroptosis, and pyronecrosis. First identified in 
human promyelocytic leukemia, HL-60 cells as an aggregating body formed during apoptosis 
(32). ASC was subsequently shown to interact directly with caspase-8, an interaction that could 
be competitively inhibited by the closely related Pyrin protein. The ASC and caspase-8 
interaction occurs between the N-terminal Pyrin Domain of ASC and the DEDs of Caspase-8 
(33). Currently a molecular understanding of this interaction is lacking. In fact it is not even 
known whether both caspase-8 DEDs are required for this interaction, let alone which specific 
residues in either ASC or caspase-8 are involved. Both Pyrin domains and DEDs are members of 
the Death Domain (DD) superfamily. DD-mediated interactions are common in inflammatory 
and cell death pathways underpinning the formation of multiprotein complexes such as: the 
Myddosome (34, 35), the Piddosome (36), the apoptosome (37, 38), the ripoptosome (39, 40), 
and the DISC (41, 42). However, usually DD interactions are homotypic in nature, meaning that 
they occur between protein folds of the same type. Hence the ASC:Caspase-8 interaction 
presents an intriguing target for future study and may provide a truly novel perspective on DD-
family interactions.  
A specific role for caspase-8 in ASC-associated cell death was originally demonstrated 
through the inhibition of apoptosis following the overexpression of a catalytically inactive 
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caspase-8 construct as well as through the action of the viral proteins CrmA and baculovirus p35. 
In addition, the genetic removal of caspase-8  resulted in the inhibition of apoptotic death 
following ASC activation (33). Further work from the group of Suda and colleagues (43, 44) 
demonstrated that ASC activation and speck formation has the capacity to result in either 
apoptotic or necrotic death and that the preise death pathway initiated was cell-type specific. 
Using an overexpression system in COS-7 cells, they showed that ASC and caspase-8 co-
localized to the speck structures and that either caspase-8 knockdown or caspase-8 inhibition led 
to a significant reduction in the degree of ASC-mediated apoptosis (44). Analysis of the 
apoptotic cascades activated by caspase-8 led to the proposition that caspase-8 promotes 
apoptosis through two distinct mechanisms. One route involves the direct cleavage of caspase-3, 
while the other is propagated through cleavage of the pro-apoptotic protein Bid. As with the 
decision to proceed via either apoptotic or necrotic death, the precise mechanism employed 
appears to be seemingly dependent on cell type (44). A more recent study has shown that the 
catalytic activity of caspase-1 is not needed for driving ASC-induced apoptosis or necrosis. 
However, in cells lacking or expressing low-levels of caspase-1 the process of caspase-8 
dependent ASC-induced apoptosis is favored. In contrast, necrosis is preferred in cells 
expressing caspase-1 (45). This is indicative of a complex regulation strategy for the initiation of 
these cell death pathways.   
Despite the well-documented connection between ASC and caspase-8, it required the 
results of a yeast-2-hybrid screen coupled with functional assays in A549 lung carcinoma cells 
before a direct link between caspase-8 and inflammasome activity was proposed (46). In this 
work, LRR-deleted NLRC4 was used as bait in a yeast-2-hybrid screen. Caspase-8 was not 
reported to interact directly with caspase-8, but instead ubiquitination of NLRC4 facilitated 
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interaction between NLRC4 and Sug1 (suppressor of gal 1), a component of the 26S proteasome. 
Using immunoprecipitation, NLRC4, Sug1, and caspase-8 were subsequently shown to co-
localize. This association resulted in caspase-8 activation and cell death in a caspase-8 dependent 
manner (46). ASC is not essential for NLRC4 signaling but has been shown to enhance the 
activity of the NLRC4 inflammasome (47–49). Consequently, this study did not address whether 
ASC was also present in these assemblies and hence mediating the recruitment of and interaction 
with capase-8. This remains a likely possibility however.  
 
Caspase-8 and the synthesis, processing, and release of pro-interleukin-1β 
IL-1β is an important pro-inflammatory mediator that signals through the type 1 interleukin-1 
receptor (50, 51). IL-1β is synthesized in an inactive precursor form, pro-IL-1β, which 
undergoes subsequent cleavage prior to secretion from the cell. The canonical activation pathway 
for IL-1β involves stimulation of pro-IL-1β synthesis as a consequence of the activation of 
NFκB signaling. This is followed by inflammasome-mediated caspase-1 activation and the 
sequential cleavage of pro-Il-1β to the active cytokine which is then released from the cell (23). 
A number of non-canonical pathways also contribute to or provide alternative routes for IL-1β 
release. These include pathways intrinsically linked to death receptor signaling and apoptosis 
(52, 53). Recent studies have assigned important roles for caspase-8 in these processes (54–57). 
It has been known for a while that a selection of non-caspase proteases including elastase, 
collagenase and cathepsin G are themselves capable of processing pro-IL-1β (58). More recently 
it has been shown that caspase-8, in addition to caspase-1, is also capable of proteolytically 
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processing pro-IL-1β into its active form. This was first reported by Maelfait and colleagues who 
demonstrated that overexpression of TRIF (Toll interleukin-1 receptor-domain protein inducing 
interferon), an adaptor protein used by both TLR3 and TLR4, resulted in the processing of pro-
IL-1β and that this could also be achieved by stimulation of the TLR3 and TLR4 signaling 
pathways with poly(I:C) and LPS (lipopolysaccharide), respectively (54). Neither the inhibition 
nor the absence of caspase-1 had a significant impact on TLR3, and TLR4 activated pro-IL-1β 
processing, whereas processing was significantly inhibited by the presence of either the viral 
protein CrmA or use of a pan-caspase inhibitor. Overexpression of caspase-8 resulted in an 
enhancement of pro-IL-1β processing, and the authors proceeded to demonstrate that 
recombinant pro-IL-1β was a substrate for direct cleavage by recombinant caspase-8 and that the 
cleavage site, D117, was the same as that utilized by caspase-1 (54).  
Activation of Fas by FasL results in a significant upregulation in pro-IL-1β production. 
This is most likely as a direct result of NFκB signaling, which can be activated in an 
inflammasome-independent manner (55). The activation of IL-1β via the Fas pathway was 
dependent on caspase-8 as both the chemical inhibition of caspase-8 and the use of Casp8/Ripk3 
double knock out BMDMs resulted in a loss in the ability to cleave pro-IL-1β. In contrast, Ripk3-
/-
 BMDMs (bone marrow derived macrophages) functioned normally in this respect. The 
processing of prol-IL-1β was dependent however on the adapter protein FADD, which plays a 
crucial role in recruiting caspase-8 to Fas. Together these experiments demonstrate an integral 
role for caspase-8 in Fas-mediated inflammasome-independent production of mature IL-1β (55). 
Caspase-8 has been intrinsically connected more recently to the processing and release of 
IL-1β following the induction of apoptosis. IAPs function to limit the apoptotic response, 
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including caspase-8 dependent apoptotic pathways. Pharmacological antagonism of IAPs 
brought about by the application of SMAC (second mitochondrial-derived activator of caspases) 
mimetics resulted in a strong induction of IL-1β in macrophages and DCs primed with LPS. A 
significant proportion of the induced pro-IL-1β processing was shown to be inflammasome-
independent but caspase-8 dependent (18). Moreover application of the proapoptotic 
chemotherapeutic agents doxorubicin and staurosporine to LPS-primed murine BMDMs resulted 
in the robust release of IL-1β (57). Somewhat surprisingly IL-1β release under these conditions 
was only minimally impaired in the absence of the inflammasome components ASC, NLRP3, 
NLRC4 or caspase-1. A detailed characterization of the signaling pathways involved showed that 
the release of IL-1β following doxorubicin or staurosporine treatment was in fact mediated by 
caspase-8. In this pathway caspase-8 was activated at ripoptosomes formed in a TRIF-dependent 
manner. This overall process was shown to be dependent on TLR4 (57). A more recent report 
has corroborated the importance of caspase-8 in mediating apoptosis related IL-1β release and 
also demonstrated that IL-1α release whilst independent of caspase-8 is regulated by necroptosis 
(56). 
 
Caspase-8 and non-canonical inflammasomes 
Evidence for a direct role for caspase-8 in non-canonical inflammasomes has recently emerged. 
Gringhuis and coworkers (59) have shown that activation of dectin-1, a member of the C-type 
lectin receptor family and important in the detection of fungal infection, also resulted in caspase-
8 mediated processing of pro-IL-1β. Stimulation of dectin-1 by different strains of pathogenic 
Candida albicans and the specific ligand curdlan resulted in the recruitment of the proteins 
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CARD9, Bcl-10 (B-cell lymphoma/leukemia 10), and MALT1 (mucosa-associated lymphoid 
tissue lymphoma translocation protein 1) into a scaffold complex to drive pro-IL-1β transcription 
and also led to the secretion of IL-1β from human dendritic cells. IL-1β release occurred in both 
caspase-1-dependent and -independent manners. The exact nature and extent of this dependency 
was influenced by the precise yeast strain being used as a stimulus. Pro-IL-1β processing was 
shown to be entirely dependent on ASC, but displayed only a small contribution from NLRP3 
driven pathways. Through the use of chemical inhibition, gene silencing and 
immunoprecipitation studies the molecular pathways involved in the caspase-1-independent 
processing of pro-IL-1β following dectin-1 stimulation were pieced together. The process was 
shown to be additionally dependent upon various components of the dectin-1 signaling pathway 
including dectin-1, Syk (spleen tyrosine kinase), CARD9, MALT1, and Bcl-10, while caspase-8 
was identified as the protease responsible for pro-IL-1β processing. Full-length uncleaved 
caspase-8 associated with MALT-1 prior to receptor activation. Following stimulation this 
complex subsequently associated with another MALT1 containing complex, MALT1-CARD9-
Bcl10, resulting in caspase-8 undergoing partial proteolysis to a 43 kDa form. No evidence was 
found to support further processing to the pro-apoptotic p18 form of caspase-8. The multiprotein 
complex formed post dectin-1 stimulation then recruits ASC in a caspase-8 dependent manner 
resulting in the formation of a non-canonical caspase-1 independent inflammasome in which 
caspase-8 serves to process pro-IL-1β. Together these data suggest that fungal pathogens can 
stimulate both IL-1β production and maturation and that this is driven through a noncanonical 
dectin-1 dependent caspase-8-dependent inflammasome (59). Further work has subsequently 
reported an essential role for caspase-8 in the promotion of β-glucan-induced cell death and also, 
in contrast to the Gringhuis study (59), NLRP3 inflammasome-dependent IL-1β maturation (60). 
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These differences may result from variations in the experimental approaches or reflect species 
based differences resulting from the use of either human (59) or murine (60) derived DCs 
(dendritic cells). Without question, it is becoming clear that β-glucan recognition receptors and 
the inflammatory proteases caspase-8 and caspase-1 coordinate cytokine secretion and cell death 
in response to fungal infections (59, 60).  
 
Caspase-8 and the canonical inflammasome: a controversial association?  
Much of the evidence outlined above suggests an important role for caspase-8 in mediating IL-
1β release due to the action of both non-canonical inflammasomes and cell death signaling 
pathways. However, when assimilating the different pieces of work performed studying the 
classical inflammasome, it rapidly becomes apparent that there is still a large degree of 
controversy within the field regarding the actual, or precise, role of caspase-8 in canonical 
inflammasome pathways.  This is contextualized in the following sections. 
Given that caspase-8 is able to process pro-IL-1β following TLR and C-type lectin 
receptor activation, we wondered whether caspase-8 was also associated with classical 
inflammasome formation via an NLR-mediated pathway. Infecting murine BMDMs with 
Salmonella resulted in the co-localisation of caspase-8 and ASC at speck-like inflammasome 
structures (61). In wildtype cells, roughly half these specks also contained caspase-1 indicating 
that both caspases could be efficiently recruited to the same inflammasome. Studies in knockout 
cells showed that whilst ASC is essential for speck formation, caspase-1 (or caspase-11) is not 
needed for the efficient recruitment of caspase-8. Similarly, caspase-1 can be efficiently recruited 
independently of caspase-1. Recruitment of caspase-8 to the inflammasome causes caspase-8 
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activation as around eighty percent of the caspase-8 positive specks were shown to harbor active 
caspase-8.  
Infection of macrophages with Salmonella Typhimurium is known to activate both the 
NLRC4 and NLRP3 inflammasomes.  Our study showed that NLRC4 activation by Salmonella 
Typhimurium, or through cytosolic delivery of the ligand flagellin, leads to direct recruitment of 
caspase-8 to the inflammasome via ASC and that caspase-8 has a direct role in the processing of 
pro-IL-1β. However, we saw no evidence that caspase-8 plays any role in mediating the rapid 
macrophage pyroptosis seen in response to Salmonella infection (61). In the same study, it was 
shown that stimulation of the NLRC4 pathway is critical for caspase-8 activation, as neither 
Nlrc4-/- nor Asc-/- cells were able to cleave and activate caspase-8, whereas Nlrp3-/- and Caspase-
1/11-/- cells both still produced the activate p18 caspase-8 isoform. Analysis of the production of 
pro-IL-1β revealed that this was significantly impaired following infection of Casp8-/-RIPK3-/- 
cells consistent with an important role for caspase-8 in the synthesis of pro-IL-1β. In contrast to 
the activation of the NLRC4 inflammasome, activation of the NLRP3 inflammasome by 
Salmonella did not induce any role for caspase-8 in the processing of pro-IL-1β (61).  
Further examination of the protein interactions indicated a d namic pattern of association 
between caspase-8 and ASC and NLRP3. In unprimed cells, caspase-8 could only be 
immunoprecipitated with ASC and not NLRP3, following LPS-mediated priming caspase-8 
associated with NLRP3 but not ASC, and with both proteins post Salmonella infection.  Relating 
this to the requirement for Signal 1 and Signal 2 in the activation of the NLRP3 inflammasome 
suggests that Signal 1 (priming) leads to an association with NLRP3 and that Signal 2 
(Salmonella infection) results in the formation of a caspase-1 caspase-8 containing 
Page 16 of 44Immunological Reviews: Submitted manuscript
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
17 
 
inflammasome that drives pro-IL-1β processing. Together, these observations are indicative of a 
major functional role for caspase-8 in classical inflammasome signaling but demonstrate discrete 
and distinct physiological roles depending on the precise inflammasome activated. 
Meanwhile in Yersinia infection models, caspase-8 and RIPK1 have both been shown to 
be key regulators of macrophage cell death, NF-κB and inflammasome activation playing a key 
role in host resistance to infection (62, 63). These two pieces of work simultaneously but 
independently demonstrated that the cell death resulting from infection of BMDMs with Yersinia 
strains was independent of caspase-1, caspase-11, NLRP3, ASC, NLRC4 and unaffected by FasL 
or TNFα. Extending the studies to include different combinations of RIPK1, RIPK3, and Casp8 
knockouts demonstrated that death was dependent on RIPK1 and Caspase-8 and that this 
occurred via FADD-dependent mechanisms as well as TRIF-dependent and TRIF-independent 
routes (62, 63). The release of IL-1β was lessened when Casp8 was knocked down or caspase-8 
inhibited, and both groups subsequently demonstrated that caspase-8 controlled the activation of 
caspase-1 and hence pro-IL-1β processing. Caspase-8 activation however was not influenced by 
caspase-1 (62, 63). 
Caspase-8 deficiency, in a RIPK3-/- background, has been shown to reduce both the 
transcriptional priming and the posttranslational activation of the canonical and non-canonical 
NLRP3 inflammasomes. The same effect is also seen with the absence of FADD (64).  This 
study also reported that deletion of Casp8 resulted in a reduction in the activation of caspase-1 
and caspase-11 by the NLRP3 inflammasome. The authors demonstrated that capsase-1 is a 
substrate for caspase-8, thereby providing a potential mechanism for this defect. The NLRC4 
inflammasome was however unaffected (64). Consist with these observations mice lacking either 
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caspase-8 or FADD showed an increased susceptibility to the effects of either LPS challenge or 
Citrobacter rodentium infection. Further evidence for the role of caspase-8 in the canonical 
inflammasome comes from the action of the endogenous caspase-8 inhibitor c-FLIPL (65).  
Deletion of c-FLIP impairs ATP- and monosodium uric acid-induced, NLRP3 dependent, IL-1β 
production in macrophages, as well as dsDNA-dependent activation of the AIM2 inflammasome.  
The precise manner in which c-FLIPL mediates NLRP3 or AIM2 inflammasome activity remains 
uncertain but may involve interaction with caspase-1, an impact on inflammasome assembly, or 
mitochondrial localization. Interestingly, while c-FLIPL is seemingly required, somewhat 
counter-intuitively given the evidence of caspase-8-mediated activation of caspase-1, for full 
NLRP3 and AIM2 inflammasome activation, this is not the case for Dectin-1-induced caspase-8 
dependent IL-1β generation. In this instance, c-FLIPL provides an inhibitory function (65). 
Caspase-8 has also recently been intrinsically connected to activation of the 
inflammasome formed by the cytosolic DNA sensor AIM2. Like NLRP1, NLRP3, and NLRC4, 
AIM2 can drive the formation of a canonical inflammasome. Infection with Francisella 
tularensis, the bacterial cause of tularaemia, or the delivery of DNA to the cytosol triggers 
AIM2/ASC-dependent caspase-3-mediated apoptosis in caspase-1-deficient macrophages (66, 
67).  These studies showed that AIM2 activation can result in the ASC-dependent, caspase-1-
independent activation of both caspase-8 and caspase-9 leading to cell death by apoptosis.  In the 
presence of casapse-8 inhibition or following caspase-8 knockdown, activation of AIM2 results 
in caspase-1-dependent death (i.e. pyroptosis) occurring. Through the utilization of a variety of 
co-localization, immunoprecipitation, and pro-IL-1β processing experiments using chimeric 
caspase constructs, it was demonstrated that caspase-8 interacts with the Pyrin domain of ASC 
via its own DEDs. This confirmed earlier observations regarding the domains involved in 
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mediating caspase-8 and ASC association (33). This work also showed that caspase-8  
specifically colocalizes with the AIM2/ASC speck (66, 67).  Interestingly, Sagulenko and 
colleagues (67) showed that there is a molecular switch in the AIM2-mediated response to 
cytosolic DNA. Specifically, they demonstrated that low concentrations of cytosolic DNA result 
in the initiation of a caspase-8 driven apoptotic death pathway but high concentrations of 
cytosolic DNA instead induce a rapid caspase-1 dependent pyroptotic death. Caspase-8 therefore 
functions as an apical caspase in the AIM2- dependent cell death pathway (67).   
 
Caspase-8 as a negative regulator of the inflammasome 
In conjunction with their work in identifying the role of caspase-8 in AIM2-dependent 
inflammasome function, Sagulenko and colleagues (67) also connected caspase-8 to the NLRP3 
inflammasome. Specifically, they showed that nigericin stimulation of the NLRP3 inflammsome 
caused the efficient activation of caspase-8. As outlined above, a number of other studies have 
also connected a positive requirement for caspase-8 function with efficient activation of the 
NLRP3 inflammasome. However, the role of caspase-8 in the NLRP3 inflammasome is not clear 
cut. Using mice specifically lacking caspase-8 in dendritic cells rather than cells from caspase 8-/-
/RIPK3-/- mice, Wallach’s group (68) has shown that caspase-8 deficiency facilitated an 
enhancement in the LPS-induced assembly and function of the NLRP3 inflammasome. Enhanced 
inflammasome assembly in the caspase-8-deficient cells lead to elevated processing of pro-IL-1β 
and pro-IL-18 and led to an increased mortality following challenge with LPS but had no effect 
on pyroptosis. An intriguing observation in this study was that Casp8-deficient DCs were 
capable of secreting both IL-1β and IL-18 following just LPS stimulation, i.e. after receiving 
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only Signal 1 and not Signal 2. This ability was lost following the deletion of RIPK3 or the 
addition of the RIPK1 inhibitor Necrostatin-1. The authors (68) verified that their cells were not 
receiving an endogenous Signal 2 as a result of the accumulation of damage-associated 
molecular patterns in the DCs themselves. This led to the hypothesis that caspase-8 exerts a more 
direct effect on inflammasome function by directly regulating or inhibiting inflammasome 
activity, potentially through a simultaneous association with FADD and NLRP3 (68).  It is 
difficult however to reconcile these observations with data showing that caspase 8 is an effector 
mechanism in both the canonical and non-canonical inflammasomes, so further work is required 
to explain these discrepancies. 
 
The structural organization of caspase-8-containing inflammasomes 
The current experimental evidence suggests the precise role of caspase 8 in the inflammasome is 
unclear and remains to be fully elucidated and may indeed serve different purposes in different 
cell types and under the influence of different stimuli.  It is clear, however, that caspase 8 can be 
recruited directly into the inflammasome complex.  The ability of the DEDs of caspase-8 to 
mediate interaction with the pyrin domain of ASC has been reported by a number of groups 
using techniques such as immunoprecipitation, confocal microscopy and through the 
construction of chimeric caspase constructs (33, 66, 67). Recent studies using 
immunofluoresence and super-resolution microscopy have enabled the direct visualization of 
caspase-8 within the endogenous ASC speck structure (61, 69). While not only confirming that 
caspase-8 can be recruited to the canonical inflammasome, the enhanced levels of resolution 
achieved using super-resolution microscopy have revealed a concentric ring-like structure to the 
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endogenous inflammasome, consisting of an outer ring of ASC, an internal NLR-containing ring, 
and a central caspase component (69). This study also confirmed that caspase-1 and caspase-8 
were present in the same inflammasome speck consistent with the reported ability of caspase-8 to 
act as a direct activator of caspase-1 (64). 
The precise molecular interactions involved in recruitment of caspase-8 remain elusive, 
and how this occurs in respect of the molecular interactions between ASC, caspase 1, and 
caspase 8 is only starting to be elucidated. It is clear that caspase-8 and caspase-1 can interact 
independently of one another with ASC via the pyrin and CARD of ASC respectively. 
Consistent with the independent nature of the caspase:ASC interaction the recruitment of 
caspase-8 to the inflammasome is dependent upon ASC and not caspase-1. Equally caspase-1 
recruitment is independent of caspase-8. This leads to the possible formation of inflammasome 
specks containing just caspase-1, just caspase-8, neither caspase, or both caspases (61) (Fig. 3). 
However, the dynamics of these events are uncertain. For example, are the caspases and ASC 
pre-associated or is the caspase recruited to the preformed speck? How do other inflammasome-
linked proteins influence caspase recruitment? Quite likely the inflammasome should be viewed 
as a dynamic protein platform in which the decision over which effector caspases to recruit is 
regulated by the nature of the stimulus received and the cell type. Indeed, we have no clue 
currently as to the stoichiometric relationship of any of the inflammasome components and 
caspase-8 is no different. However, a recent quantitative mass spectroscopy based study of the 
stoichiometry of the DISC revealed that in this macromolecular signaling complex caspase-8 is 
likely to be present at around a ninefold molar excess to FADD (70). More intriguingly, 
overexpression of the caspase-8 DED has shown them to be capable of forming filamentous 
structures in the cell (71). Although these filaments were not reported to form in the context of 
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the full-length pro-caspase-8 protein, it raises interesting parallels with the recent reports of 
filamentous ASC induced upon overexpression (72). It remains to be seen whether similar 
aggregation is behavior for caspase-8 is observed in relation to its role in inflammasome 
function. 
 
Caspase-8 and inflammatory disease 
Aside from or in some instances associated with its role in inflammasome functionality, caspase-
8 has been directly implicated in a number of inflammatory conditions. Specific deletion of 
Casp8 from murine intestinal epithelial cells, keratinocytes, and hepatocytes leads to the 
induction of ileitis and chronic skin and liver inflammation respectively (73–75). The absence of 
Casp8 from intestinal epithelial cells resulted in the dysregulation of necroptosis and increased 
cell death (75). Interestingly, these mice did not appear to possess Paneth cells and contained a 
significantly reduced number of Goblet cells. As a result, intestinal homeostasis was severely 
disrupted, spontaneous inflammation occurred, especially in the ileum, and they showed an 
enhanced susceptibility to the development of colitis (75). Conditional deletion of Casp8 from 
hepatocytes led to an increase in the susceptibility of the mice to infection with Listeria 
monocytogenes and an alteration in the pattern of recovery following partial hepatectomy (74). In 
the absence of caspase-8 initial cellular proliferation was impaired; however, the rate of new 
growth became more rapid than that of the control mice and lasted for longer. This led to an 
overall increase in liver size and ultimately induced a chronic inflammatory state. Interestingly 
the prolonged enhanced proliferation only occurred in mice of a mixed genetic background and 
not in a pure C57Bl/6 background (74). Removal of Casp8 from keratinocytes caused chronic 
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skin inflammation due to an increase in the IRF3 (interferon response factor 3)-dependent 
response to endogenous mediators of inflammation and also resulted in enhanced gene activation 
following DNA transfection (73).  
The above examples all showcase inflammation that occurs as a result of Casp8 deletion. 
This suggests that at least in these tissues caspase-8 plays an important role in the suppression of 
cellular inflammation. However, the clinical effects of caspase-8 are far from straightforward, 
and caspase-8 has also been directly implicated with a number of conditions: the progression of 
geographic atrophy, an age-related form of macular degeneration (76), the progression of acute 
glaucoma (77), and neurotoxicity resulting from microglia activation (78).  More specifically, the 
retinal pigmented epithelium of individuals with geographic atrophy showed an increase in 
caspase-8 expression and a role for Fas-ligand dependent activation of caspase-8 in the reduced 
levels of endoribonuclease DICER1, the upregulation of IL-18, and the accumulation of Alu 
RNA characteristic of disease progression (76). Similarly in rodent models of acute glaucoma, 
caspase-8 was shown to be crucial for the TLR4-dependent upregulation of pro-IL-1β required 
for retinal ganglion cell death in a caspase-1-dependent NLRP3-dependent manner. Inhibition of 
caspase-8 protected against cell death (77). Meanwhile the addition of LPS to microglial cultures 
resulted in TLR4-driven activation of caspase-8 and the subsequent caspase-8-dependent 
activation of caspase-3 and caspase-7. Other caspase-8 substrates, including Bid and RIPK1, 
were not cleaved in this system. Active caspase-8 was also identified in the microglial of patients 
with either Parkinson’s disease or Alzheimer’s disease, suggesting an important role for caspase-
8 in these neurodegenerative disorders (78). 
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Virus-mediated inhibition of caspase-8  
The role of caspase-8 is not just limited to a direct part in the inflammatory and death pathways 
or even as a contributor to the control of bacterial infection. Caspase-8 is also an important 
component of the antiviral response, a role that has long been acknowledged since the first 
reports of viral targeted inhibition of caspase-8 function (79). The importance of caspase-8 for 
this purpose is exemplified by the wide repertoire of viral proteins that function directly either as 
caspase-8 inhibitors, or target other points in the caspase-8, FADD, and RIPK1-RIPK3 signaling 
pathways (80). For example, poxviral proteins from the serpin family have been shown to bind 
directly to caspase-8 and as a result disrupt its functionality. In addition the activation of caspase-
8 can be specifically inhibited by viral proteins such as the adenoviral E3 protein, p35 from 
baculovirus and the vICA (viral inhibitor of caspase-8 induced apoptosis) protein found in strains 
of cytomegalovirus (81–85). The net result of viral induced caspase-8 inhibition is normally to 
limit or reduce the inhibition of necroptotic signaling as a result of reducing the extent of RIPK1 
and RIPK3 cleavage. Disruption of capase-8-mediated RIPK1-RIPK3 necrosome formation is 
also mediated by the poxviral proteins CrmA and B13R. Indeed, CrmA is capable of inhibiting 
caspase-1, -4, -5, and -8 activity (86), attributes that have made CrmA a useful tool for the non-
pharmacological inhibition of caspase functionality over the years. A whole subset of viral 
proteins homologous to cFLIP-long and cFLIP-short, and known as vFLIPs, function to inhibit 
the apoptotic role of caspase-8. In some cases, these vFLIPs also target the necroptotic RIPK1-
RIPK3 pathway. For example, the rodent cytomegalovirus protein vIRA interferes with the 
interaction between RIPK1 and RIPK3. This has the effect of stopping the progression of 
necroptosis, which would otherwise be initiated following the inhibition of caspase-8 by the 
virally encoded protein vICA (87). While this is an example of both the caspase-8-associated 
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apoptotic and necroptotic death pathways being disrupted by viral infection, in many cases 
necroptotic death does occur. This observation suggests that necroptotic death may be a more 
favorable outcome for the virus than other more classical cell defense or death routes. In addition 
to its role in antiviral apoptotic and necroptotic death, alternative functions for caspase-8 in the 
cellular response to viral infection have also been reported. These include the activation of 
capase-8 in response to cell stimulation with dsRNA, a role in the regulation of IRF3 signaling 
following RIG-I activation, and formation of a TRADDosome-like complex associated with 
MAVS (mitochondrial antiviral associated protein) (88–90). Clearly caspase-8 is a pivotal 
molecule in the antiviral response and it is likely that our understanding of the functional 
repertoire and protective involvement of caspase-8 against viral pathogens will continue to 
expand over the next few years. 
 
Burning questions and future directions 
The role of caspase-8 in inflammation, particularly in relation to inflammasome-mediated 
signaling, will remain an important area of study in the coming years. Caspase-8 provides a 
pivotal connection between the death and inflammatory pathways—pathways intrinsically linked 
in cell fate and disease pathogenesis. Understanding more fully how precisely caspase-8 
contributes to inflammation will help our understanding of the delicate balance between 
inflammatory and death cell phenotypes.  
Caspase-8 already functions as a molecular switch: in the cellular decision whether to 
proceed down NFκB-mediated pro-survival pathways or initiate apoptotic death; in the switch 
between apoptotic or necroptotic death; and in the cases of some viruses, whether to inhibit 
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apoptotic death, necroptotic death, or both. Do bacterial infections target caspase-8 at all? Are 
some of the inflammasome inhibitors with an unknown mechanism of action actually caspase-8 
inhibitors? DISC-mediated activation of caspase-8 could also be viewed as a molecular switch 
dependent on the extent of external stimuli and hence the number of DISCs formed. Could 
caspase-8 also act as a molecular switch for inflammatory signaling? Determining whether or not 
caspase-8 acts as a negative regulator of inflammasome signaling, how precisely it assists in the 
activation of caspase-1 and the processing of pro-IL-1β, and identifying how the role of caspase-
8 differs in the face of different inflammatory stimuli and in different cell types are all important 
questions to address. Finally, will caspase-8 present itself as a suitable target for the modulation 
of the inflammatory response and the treatment of either acute of chronic inflammatory 
conditions?  
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Figure Legends 
Fig. 1. The organization of caspase-8. (A) Syntenic comparison of the immediate environment 
surrounding Casp8, the gene encoding caspase-8, between humans and mice. Genes in blue are 
on the forward strand, genes in green are on the reverse strand. (B) Graphical representation of 
the domain organization of the caspase-8 protein. The key aspartic acid residues acting as 
cleavage sites during protein activation are marked with arrows and labelled. DED, death 
effector domain; p18 and p10, catalytic sub-domains.  
Fig. 2. Simple schematic representation of the involvement of caspase-8 in death-receptor 
signaling. (A) Engagement of CD95 or TRAIL1/2 results in the recruitment of FADD and pro-
caspase-8 to the cytosolic death domain of the receptor, which in turn results in the formation of 
a DISC (death-inducing signaling complex). Sites of caspase-8 cleavage are marked by a yellow 
star. (B) Following TNFR1 activation caspase-8 can ultimately form a complex, the 
‘TRADDosome’ with TRADD, FADD, RIPK1, and RIPK3. Caspase-8-mediated cleavage of 
RIPK1 and RIPK3 inhibits necroptosis and directs cell death down the apoptotic pathway. (C) 
When caspase-8 is inhibited, degraded, or deleted, RIPK1 and RIPK3 do not get cleaved. RIPK1 
phosphorylates RIPK3 which activates neroptotic death. DD, death domain; DED, death effector 
domain. 
Fig. 3. Schematic of the possible interactions between ASC and caspase-1 and caspase-8. 
Prior to inflammasome stimulation, it is possible that ASC may bind to both, either, or neither of 
pro-caspase-8 and pro-caspase-1 (left hand side). Upon receipt of ‘Signal 2’, the inflammasome 
is activated leading to formation of an ASC-driven speck. Pro-caspase-8 and pro-caspase-1 can 
undergo autoproteolytic activation through a proximity induced mechanism. However, in the 
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case when both caspases are present in the same inflammasome, this can facilitate caspase-8-
mediated processing of pro-caspase-1 and has the potential to lead to enhanced pro-IL-1β 
processing. The molecular structures of the ASC pyrin (deep pink) and CARD (light blue) were 
generated in PYMOL from the protein data bank file 2KN6 (91).  
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